Boston Scientific cyberattack disrupts global operations and shipments
On August 26, 2026, Boston Scientific disclosed a cybersecurity incident that disrupted its global IT systems, halting order processing and product shipments. The medical device maker activated incident response protocols with third-party experts, but the full financial and operational impact remains unknown. Shares fell up to 5.9% in premarket trading. The attack compounds existing challenges, including a weak profit forecast, reduced Watchman heart implant demand, and a product recall. The company has not provided a timeline for system restoration.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection
Cross-source coverage
Wire timeline
Boston Scientific's ordering, shipping disrupted in cyberattack
Boston Scientific disclosed a cyberattack on Wednesday that has disrupted its ability to process and ship customer orders globally. The medical device maker identified the attack on Tuesday and filed a report with the SEC. The attack affected certain IT systems and business applications, causing a network outage and operational disruptions. The company has activated response protocols and is investigating with third-party cybersecurity experts, but the timeline for full restoration is unknown. Boston Scientific has not yet determined if the incident will have a material financial impact. The company's shares dropped nearly 6% in premarket trading. This attack follows similar incidents at other medical device companies including Medtronic, Abbott, Intuitive, and Stryker, with Stryker's earlier attack having significant operational and financial consequences.
Boston Scientific cyberattack disrupts ordering and shipping operations
Boston Scientific disclosed a cyberattack on Wednesday that has disrupted its ability to process and ship customer orders globally. The medical device maker identified the attack on Tuesday and filed a report with the Securities and Exchange Commission. The attack affected certain information technology systems and business applications, causing a network outage and operational disruptions. The company has activated response protocols and is investigating with third-party cybersecurity experts, but the timeline for full restoration is unknown. Boston Scientific has not yet determined if the incident will have a material financial impact. The company's shares dropped nearly 6% in premarket trading. Boston Scientific joins a growing list of medical device companies hit by cyberattacks in 2026, including Medtronic, Abbott, Intuitive, and Stryker. Stifel analysts noted increased uncertainty regarding the company's 2026 revenue and earnings outlook due to the attack.
Boston Scientific Shares Fall 5% on Cybersecurity Incident and Product Recall
Boston Scientific (NYSE:BSX) shares fell 5% on August 26, 2026, following a cybersecurity incident that disrupted global operations and shipping, and a product recall for its ENROUTE Transcarotid Neuroprotection System (NPS) due to FDA concerns about potential separation of the arterial sheath tip. The stock closed at $48.17, down 3.38%, with trading volume 48% above average. The company has seen its stock drop 55% over the past year amid weaker earnings, disappointing Watchman sales, and slashed guidance. Peers Abbott Laboratories fell 1.75% while Medtronic rose 0.95%. Management is working to restore systems but cannot yet determine material impact.
Show 4 older updatesHide older updates
Boston Scientific Stock Crashes After Cybersecurity Incident
Boston Scientific (BSX) stock fell sharply on August 26, 2026, dropping as much as 5.9% after the company disclosed a cybersecurity incident in a regulatory filing. The medical device maker reported a 'global disruption' to its IT systems, impacting its ability to process and ship customer orders. The company activated incident response protocols, but the full operational and financial impact remains unknown. The article also references IBM's 2026 'Cost of a Data Breach' report, noting the average cost of a breach in the U.S. reached a record $11.5 million. Investors are advised to monitor developments as the investigation continues.
Boston Scientific cyberattack disrupts global operations, shipments
Boston Scientific disclosed on August 26, 2026, that a cyberattack detected the previous day is disrupting its global operations, including its ability to process and ship customer orders. The company activated incident response protocols and brought in third-party cybersecurity experts, but the full operational and financial impact remains unknown. Boston Scientific stock fell 5.8% in premarket trading following the disclosure. The cyberattack comes at a difficult time for the company, which had already lost nearly half its value this year due to a disappointing profit outlook and reduced demand for its Watchman heart implant. The company also recently trimmed its full-year profit outlook and approved a restructuring initiative involving sourcing, logistics, and manufacturing relocations.
Boston Scientific hit by cyberattack disrupting product shipments; shares fall
Boston Scientific, a $72 billion medical device maker, disclosed in an SEC filing on Wednesday that it was hit by a cyberattack this week. The attack is disrupting the company's access to information systems and applications, including those used for shipping products. The company stated it is working diligently to restore affected functions but the timeline for full restoration is not yet known. Shares fell 3.5% in premarket trading following the disclosure. The stock had already been under pressure this year, nearly cut in half after a weak profit forecast in the first quarter. The company manufactures devices such as pacemakers and stents.
Boston Scientific shares fall after cybersecurity incident disrupts operations
Boston Scientific (NYSE: BSX) disclosed a cybersecurity incident on Tuesday that has affected some of its information technology systems, disrupting parts of its operations. The incident has restricted access to certain business applications, impacting the company's ability to process customer orders and ship products. Shares fell 4% in premarket trading on Wednesday following the disclosure. The company has launched an investigation with third-party cybersecurity specialists to assess and contain the threat. Boston Scientific has not yet determined the full scope of the incident or whether it will have a material financial impact, and no timetable for system restoration has been established. Investors are closely monitoring the duration of the disruption and potential consequences for customer orders and shipments.